- Cancer Antibodies
- Metabolism Antibodies
- New Antibodies
- Crown Antibodies
- Secondary Antibodies
- Stem Cells
- Neurodegeneration >
- Goat Antibodies
- GPCR Antibodies
- Infectious Disease and Small Molecules
- Loading Control Antibodies
- Tag Antibody
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Biological Process >
- FL cDNA Clones
NKIRAS1 Antibody (Center)
Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
United StatesOrdering Information
AlbaniaAustraliaAustriaBelgiumBosnia & HerzegovinaBrazilBulgariaCanadaChinaCroatiaCyprusCzech RepublicDenmarkEstoniaFinlandFranceGermanyGreeceHong KongHungaryIcelandIndiaIndonesiaIrelandIsraelItalyJapanKoreaLatviaLithuaniaLuxembourgMacedoniaMalaysiaMaltaNetherlandsNew ZealandNorwayPakistanPolandPortugalRomaniaSerbiaSingaporeSlovakiaSloveniaSouth AfricaSpainSwedenSwitzerlandTaiwanTurkeyUnited KingdomUnited StatesVietnamOthers
|Catalog #||Size||Availability||Available Date|
(40 western blots)
|Backorder||4 months||DISCONTINUED INQUIRE CLICK Add to cart|
(8 western blots)
|Backorder||4 months||DISCONTINED INQUIRE CLICK Add to cart|
- Citations : 0
NKIRAS1 Antibody (Center) - Product Information
|Other Accession||Q9BH04, NP_065078.1|
|Calculated MW||21643 Da|
|Antigen Region||48-76 aa|
NKIRAS1 Antibody (Center) - Additional Information
|Gene ID 28512|
NKIRAS1; KBRAS1; NF-kappa-B inhibitor-interacting Ras-like protein 1; I-kappa-B-interacting Ras-like protein 1
This NKIRAS1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 48-76 amino acids from the Central region of human NKIRAS1.
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
NKIRAS1 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.
NKIRAS1 Antibody (Center) - Protein Information
Atypical Ras-like protein that acts as a potent regulator of NF-kappa-B activity by preventing the degradation of NF-kappa-B inhibitor beta (NFKBIB) by most signals, explaining why NFKBIB is more resistant to degradation. May act by blocking phosphorylation of NFKBIB and mediating cytoplasmic retention of p65/RELA NF-kappa-B subunit. It is unclear whether it acts as a GTPase. Both GTP- and GDP-bound forms block phosphorylation of NFKBIB.
NKIRAS1 Antibody (Center) - Related Products
NKIRAS1 Antibody (Center) - Research Areas
NKIRAS1 Antibody (Center) (Cat. #AP17459c) western blot analysis in SK-BR-3 cell line lysates (35ug/lane).This demonstrates the NKIRAS1 antibody detected the NKIRAS1 protein (arrow).
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
Atypical Ras-like protein that acts as a potent regulator of NF-kappa-B activity by preventing the degradation of NF-kappa-B inhibitor beta (NFKBIB) by most signals, explaining why NFKBIB is more resistant to degradation. May act by blocking phosphorylation of NFKBIB and mediating cytoplasmic retention of p65/RELA NF-kappa-B subunit. It is unclear whether it acts as a GTPase. Both GTP-and GDP-bound forms block phosphorylation of NFKBIB.
Gerashchenko, G.V., et al. Exp. Oncol. 32(2):71-75(2010)
Dieguez-Gonzalez, R., et al. Ann. Rheum. Dis. 68(4):579-583(2009)
Barrios-Rodiles, M., et al. Science 307(5715):1621-1625(2005)
Chen, Y., et al. Mol. Cell. Biol. 24(7):3048-3056(2004)
Chen, Y., et al. J. Biol. Chem. 278(25):23101-23106(2003)